by Suzanne D. Vernon, PhD | Jan 10, 2025 | Long COVID, ME/CFS, Research News
The emergence of SARS-CoV-2, the virus responsible for COVID-19, swept across the globe with an unparalleled speed and severity. As a researcher dedicated to understanding how viral infections lead to chronic illness, I knew this pandemic would have far-reaching...
by Suzanne D. Vernon, PhD | Dec 10, 2024 | BHC News, Research News
Promising Clinical Trial Results: Advancing ME/CFS and Long COVID Treatment by Suzanne Vernon, PhD, Director of Research At the Bateman Horne Center (BHC), we are committed to finding effective treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)...
by Suzanne D. Vernon, PhD | Dec 6, 2023 | BHC News, Long COVID, Research News
This past summer, we completed an open-label, proof of concept trial using a combination of valacyclovir, the generic form of Valtrex, and celecoxib, the generic form of Celebrex to see if it improved symptoms in women sick with Long COVID. The combination of these...
by Suzanne D. Vernon, PhD | Jul 28, 2023 | BHC News, Research News
I met Armin Alaedini in 2008 at a meeting in San Francisco that was about solutions for Lyme and other tick-borne diseases through cutting edge science. I was fascinated by his presentation on immunological findings in post-treatment Lyme disease and I approached him...
by Suzanne D. Vernon, PhD | Jun 30, 2023 | Long COVID, ME/CFS, Orthostatic Intolerance, Press, Research News
This week our paper about possible causes of brain fog in ME/CFS and Long COVID was published in Frontiers of Neuroscience. This study included a large group of ME/CFS patients, Long COVID patients, and matched healthy controls. We hypothesized that cognitive...